Bone conduction treatment determination and care pathway

clinician-phone.jpg

What you'll find on this page

Treatment determination and care pathway

Follow these steps for a consistent and streamlined candidacy and treatment process. For more details, please go to the Resources section to download the Bone Conduction Protocol.

Bone Conduction Solution Treatement Pathway Infographic.png

 


Cochlear Bone Conduction Solutions candidacy, evaluation and fitting protocol

icon-green-candidacy.png

Candidacy identification

Assess audiological status, medical etiologies and impact to daily life to determine if bone conduction may be an appropriate solution. Consider the following:

  • Type of hearing loss (conductive or mixed hearing loss, single-sided deafness)
  • Common etiologies (microtia/atresia, chronic otitis media, middle ear dysfunction/ossicular disease, or conditions contraindicating reliable use of conventional hearing aids)
  • Daily interactions (struggle with communication, need for reliable and consistent hearing, and quality of life)

icon-blue-demonstration.png

Demonstration and evaluation

Allow patients to experience hearing through bone conduction with a demonstration.

baha demos.png

Conduct a bone conduction evaluation to assess the candidate’s performance to assist with treatment determination, help predict outcomes, and collect a baseline for continued monitoring.

icon-purple-check.png

Treatment determination

Develop an audiological treatment plan in conjunction with medical treatment, to meet patient lifestyle needs.

Patient qualification
  • Conductive or Mixed Hearing Loss (CHL or MHL) with PTA bone conduction threshold ≤55 dB (500, 1000, 2000, 3000 Hz)
  • Meets age requirement*†
  • Motivated to proceed with a surgical hearing implant solution
Recommendation
icon-osia-system.png

Cochlear™ Osia® System

Patient qualification
  • Single-sided deafness
    • Poor ear – Non-functional hearing (i.e. profound hearing loss)
    • Good ear – PTA air conduction threshold ≤ 20 dB SNHL (i.e. normal hearing, 500, 1000, 2000, 3000 Hz)
  • Meets age requirement*†
  • Motivated to proceed with a surgical hearing implant solution
Recommendation
icon-osia-system.png

Cochlear Osia System

or

Conduct a cochlear implant evaluation for a Cochlear Nucleus® System:
Learn more

Patient qualification
  • Conductive or Mixed Hearing Loss (CHL or MHL) with PTA bone conduction threshold ≤55 dB (500, 1000, 2000, 3000 Hz)
  • No age requirement
  • Motivated to proceed with a non-surgical hearing solution
Recommendation
icon-baha-start.png

Cochlear™ Baha® Start with Baha 6 Max Sound Processor worn with a SoundArc™ or Softband

Additional recommendations for specific cases

Patient with factors that preclude an Osia System
Recommendation

Cochlear™ Baha® Connect with Baha 6 Max Sound Processor

Patient with bone conduction PTA threshold between 55-65 dB
Recommendation

Cochlear Baha Connect with Baha 5 SuperPower Sound Processor

or

Conduct a cochlear implant evaluation for a Cochlear Nucleus® System:
Learn more

Patient suitable for a Baha Solution and requires additional clearance between the skin and the Baha 6 Max Sound Processor
Recommendation

Consider the Baha 6 Max Sound Processor with the 2mm Extended snap coupling, instead of the LowPro™ snap coupling

icon-yellow-treatment.png

Patient treatment, fitting and monitoring

Provide and evaluate improved sound quality and speech intelligibility with comfortable wear for the recipient to use their bone conduction solution to the maximum potential.

Consider utilizing available Remote Care solutions to provide quality care without the need for patients to visit the clinic.

Resources

Disclaimer

This material is intended for health professionals. If you are a consumer, please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

For a full list of Cochlear’s trademarks, please visit our Terms of Use page.

*In the United States and Canada, the placement of a bone-anchored implant is contraindicated in children below the age of 5. In the United States, the Osia 2 System is cleared for children ages twelve and older. In Canada, the Osia 2 System is approved for children ages five and older.

†In the United States and Canada, the Nucleus System for single-sided deafness is cleared for children ages five and older